Parents suspecting diplegia should take their child to the doctor to potentially get an earlier diagnosis. Treatment and care
This is broken up by age categories. Different ages require different forms of treatment which may include: therapy, bracing, walkers, wheelchairs, and surgery. Currently the treatments for children are concentrated primarily on independent walking but instead a more independence-oriented therapeutic approach would be more beneficial. This way the child can still focus on walking but at the same time be taught to do things for themselves while using the best method of walking for them. This could include using a walker or wheelchair to get around and do things easier than focusing all the attention on walking so early. For people requiring surgery, distal hamstring lengthening is the most common operation performed because it reduces knee flexion and improves knee motion. Birth to 1 year
“This first year sees the development of many milestones, such as head control, reaching out for a toy, sitting, starting to vocalize sounds, and finger feeding.”  Most parents want their children to excel very fast, but there is a wide upper and lower range of development time for premature babies so its very hard to diagnose cerebral palsy or diplegia this early. The most common symptom of a child with diplegia is stiff lower extremities. This should become apparent by the six month mark which means he or she does not have severe diplegia.
They are so expensive that gene therapy for haemophilia might be less expensive, especially for people with severe hemophilia. See also
Damoctocog alfa pegol, a recombinant antihemophilic factor VIII
Efmoroctocog alfa, a recombinant antihemophilic factor VIII
Moroctocog alfa, a recombinant antihemophilic factor VIII
Susoctocog alfa, a recombinant antihemophilic factor VIII
Turoctocog alfa, a recombinant antihemophilic factor VIII

References
External links
"Blood-coagulation factor VIII, procoagulant". Drug Information Portal. U.S. National Library of Medicine. "Beroctocog alfa". Drug Information Portal. U.S. National Library of Medicine. "Antihemophilic Factor (Recombinant) Monograph for Professionals". Drugs.com. "Antihemophilic Factor (Recombinant), Porcine Sequence Monograph for Professionals". Drugs.com. "Antihemophilic Factor (recombinant), Fc Fusion Protein Monograph for Professionals". Drugs.com. "Antihemophilic Factor (recombinant), Glycopegylated-exei Monograph for Professionals". Drugs.com.